Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_assertion description "[The epidermal growth factor receptor (EGFR) mutant of EGFRvIII is highly expressed in glioma cells, and the EGFRvIII-specific dendritic cell (DC)-induced tumor antigen-specific CD8(+) cytotoxic T lymphocytes (CTLs) may hold promise in cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_assertion evidence source_evidence_literature NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_assertion SIO_000772 24816916 NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_assertion wasDerivedFrom befree-20150227 NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_assertion wasGeneratedBy ECO_0000203 NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP992021.RAYWpnHkKzrjFNhkt5Hg4046WH-MfYpdbyEn4Gw-PMzsQ130_provenance.